IPHA
Innate Pharma
NASDAQ: IPHA · HEALTHCARE · BIOTECHNOLOGY
$1.48
+5.71% today
Updated 2026-04-29
Market cap
$138.87M
P/E ratio
—
P/S ratio
15.42x
EPS (TTM)
$-0.64
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
Innate Pharma (IPHA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $24.77M | $69.25M | $63.15M | $60.86M | $64.22M | $48.01M | $60.11M | $48.30M | $55.88M | $90.69M | $305.96M | $281.58M | $255.02M | $451.22M | $401.36M | $307.42M | $267.50M | $207.86M | $175.19M | $111.06M |
| Cash & equivalents | $2.59M | $6.16M | $2.48M | $10.88M | $46.45M | $31.82M | $46.61M | $30.58M | $38.36M | $64.29M | $152.87M | $175.91M | $99.37M | $152.31M | $202.89M | $136.79M | $103.76M | $84.22M | $70.61M | $66.40M |
| Current assets | $21.21M | $64.27M | $55.59M | $52.21M | $56.27M | $40.66M | $52.98M | $41.00M | $49.35M | $79.31M | $252.13M | $230.08M | $137.52M | $319.64M | $237.60M | $173.33M | $138.26M | $139.83M | $148.01M | $85.74M |
| Total liabilities | $4.70M | $12.89M | $13.55M | $19.52M | $17.10M | $14.49M | $33.48M | $24.93M | $15.60M | $16.06M | $233.89M | $195.41M | $169.07M | $283.98M | $183.94M | $151.45M | $160.06M | $153.71M | $132.29M | $102.22M |
| Current liabilities | $2.26M | $10.04M | $10.55M | $12.82M | $9.27M | $7.37M | $15.49M | $15.36M | $9.28M | $10.78M | $60.16M | $76.44M | $73.91M | $196.74M | $121.82M | $45.49M | $79.89M | $41.34M | $39.64M | $32.98M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | $1.47M | $1.05M | $2.42M | $2.03M | $14.10M | $16.95M | $13.50M | $38.93M | $30.61M | $22.18M |
| Shareholder equity | $20.07M | $56.37M | $49.61M | $41.34M | $47.12M | $33.52M | $26.63M | $23.36M | $40.29M | $74.63M | $72.07M | $86.17M | $85.96M | $167.24M | $217.42M | $155.97M | $107.44M | $54.15M | $51.90M | $8.83M |
| Retained earnings | $-19.77M | $-26.14M | $-34.46M | $-44.06M | $-63.22M | $-76.88M | $-6.98M | $-87.07M | $-89.96M | $-109.53M | $-116.23M | $-103.59M | $-151.98M | $-134.79M | $-155.67M | $-220.46M | $-272.21M | $-330.32M | $-336.89M | $-386.36M |
| Accounts receivable | — | $6.88M | $2.32M | $13.86M | $7.07M | $5.11M | — | $2.95M | $2.40M | $979000.00 | $9.95M | $25.55M | $15.08M | $146.64M | $2.82M | $11.33M | $1.66M | $3.14M | $46.49M | $1.64M |
| Inventory | — | — | — | — | — | — | — | $1.15M | $940000.00 | $1.49M | $278000.00 | $513000.00 | $6.33M | $1.00 | $5.60M | $3.28M | $-4.95M | $-2000.00 | $-3.37M | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1000.00 | $2000.00 | $-41.00M | — | — |